Showing results (21-30 of 71) with videos related to
Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxelDanny Chen, Di Song, M Guillaume Wientjes, et al.Advanced Drug Delivery Reviews|May 17, 2011
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumorYinghuan Li, Jie Wang, M Guillaume Wientjes, et al.The AAPS Journal|February 3, 2019
Systemic Bioequivalence Is Unlikely to Equal Target Site Bioequivalence for Nanotechnology Oncologic ProductsJessie L-S Au, Ze Lu, Roberto A Abbiati, et al.Pharmaceutical Research|June 11, 2005
Formulating paclitaxel in nanoparticles alters its dispositionTeng Kuang Yeh, Ze Lu, M Guillaume Wientjes, et al.The AAPS Journal|August 20, 2015
High Sensitivity RT-qPCR Assay of Nonlabeled siRNA in Small Blood Volume for Pharmacokinetic Studies: Application to Survivin siRNABertrand Z Yeung, Ze Lu, Guillaume M Wientjes, et al.Pharmacological Reviews|March 9, 2019
Target Site Delivery and Residence of Nanomedicines: Application of Quantitative Systems PharmacologyJessie L-S Au, Roberto A Abbiati, M Guillaume Wientjes, et al.Pharmaceutical Research|October 22, 2003
Drug delivery and transport to solid tumorsSeong Hoon Jang, M Guillaume Wientjes, Dan Lu, et al.Journal of Translational Medicine|January 22, 2008
Quantitative image analysis of intra-tumoral bFGF level as a molecular marker of paclitaxel resistanceColin T Walsh, Yong Wei, M Guillaume Wientjes, et al.The AAPS Journal|October 3, 2007
Biodegradable intraprostatic doxorubicin implantsRonnie Ortiz, Jessie L-S Au, Ze Lu, et al.Nanomedicine (London, England)|November 15, 2011
Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor primingJie Wang, Ze Lu, Yue Gao, et al.Pageof 8